Vaccine/device combination for prevention of HFRS
A-17088
Phase 1 mab completed
Quick answer
Vaccine/device combination for prevention of HFRS for Hemorrhagic Fever With Renal Syndrome is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Hemorrhagic Fever With Renal Syndrome
- Phase
- Phase 1
- Modality
- mab
- Status
- completed